• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA• Launch preparations are underway to bring the second approved golimumab biosimilar to patients acro...
View DetailsGuangzhou,China – July 2025 – Bio-Thera Solutions, Inc. (688177:SH), a commercial-stagebiopharmaceutical company developing a pipeline of innovative therapies andbiosimilars, today announced that the Independent Data Monitoring Committee(IDMC) has re...
Guangzhou, China– June 25, 2025 – Bio-TheraSolutions Inc. (688177:SH), acommercial-stage biopharmaceutical company developing a pipeline of innovativetherapies and biosimilars, today announced that dosing has begun in a phase 3clinical study for BAT8...
· This new agreement marksthe fourth product in the partnership and introduces a potential cost-effectivealternative to oneof the world’s top-selling biologics—broadening access to specialty care forpatients with chronic inflammatory diseases. · The ...
